olivier cuvillier
UPR8241 Laboratoire de Chimie de Coordination (LCC)
Toulouse, France
Associate Editor
Pharmacology of Anti-Cancer Drugs
UPR8241 Laboratoire de Chimie de Coordination (LCC)
Toulouse, France
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Wrocław
Wrocław, Poland
Associate Editor
Experimental Pharmacology and Drug Discovery
Department of Life Sciences, University of Roehampton London
London, United Kingdom
Associate Editor
Inflammation Pharmacology
LUM GiuseppeDeGennaro University
Casamassima, Italy
Associate Editor
Pharmacology of Ion Channels and Channelopathies
University of Catania
Catania, Italy
Associate Editor
Experimental Pharmacology and Drug Discovery
University of Palermo
Palermo, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Humanitas University
Rozzano, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Université de Sherbrooke
Sherbrooke, Canada
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Regional University of Cariri
Crato, Brazil
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Centre Hospitalier Universitaire de Toulouse
Toulouse, France
Associate Editor
Renal Pharmacology
University of Calgary, Adjunct Associate Professor
Calgary, Canada
Associate Editor
Inflammation Pharmacology
University of Palermo
Palermo, Italy
Associate Editor
Pharmacogenetics and Pharmacogenomics
Fundeni Clinical Institute
Bucharest, Romania
Associate Editor
Pharmacology of Anti-Cancer Drugs
Université Toulouse III Paul Sabatier
Toulouse, France
Associate Editor
Neuropharmacology
Federal University of Rio Grande do Sul
Porto Alegre, Brazil
Associate Editor
Experimental Pharmacology and Drug Discovery
Federal University of Pernambuco
Recife, Brazil
Associate Editor
Gastrointestinal and Hepatic Pharmacology